11-121109339-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PP3PP5BS1_Supporting
The NM_005422.4(TECTA):c.327C>T(p.Gly109Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,613,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005422.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TECTA | ENST00000392793.6 | c.327C>T | p.Gly109Gly | synonymous_variant | Exon 4 of 24 | 5 | NM_005422.4 | ENSP00000376543.1 | ||
TBCEL-TECTA | ENST00000645041.1 | c.1236C>T | p.Gly412Gly | synonymous_variant | Exon 9 of 10 | ENSP00000496315.1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251416Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135884
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727240
GnomAD4 genome AF: 0.000237 AC: 36AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74290
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:2
- -
Published functional studies suggest a damaging effect on gene splicing due to activation of a cryptic splice donor site (PMID: 35870179); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 35870179) -
This sequence change affects codon 109 of the TECTA mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the TECTA protein. This variant is present in population databases (rs727504830, gnomAD 0.003%). This variant has been observed in individual(s) with autosomal recessive deafness (PMID: 35870179; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 179381). Studies have shown that this variant alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 35870179). For these reasons, this variant has been classified as Pathogenic. -
- -
TECTA-related disorder Pathogenic:1
The TECTA c.327C>T variant is not predicted to result in an amino acid change (p.=). This variant has been reported in the homozygous and compound heterozygous states in multiple unrelated individuals with nonsyndromic hearing loss, with an in vitro splicing assay demonstrating this variant results in the creation of a cryptic splice donor site, frameshift and premature termination (Chen. 2022. PubMed ID: 35870179). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Gly109Gly variant in TECTA has been reported by our laboratory in three individuals with hearing loss, including this case. In one family, the proband was compound heter ozygous for a second variant of uncertain significance in TECTA; however, the p. Gly109Gly variant did not segregate in the individual's affected sibling and the refore TECTA was ruled out as a cause of hearing loss. In the second family, the proband carried a pathogenic variant in TECTA that was likely in trans, as one parent was tested for the two variants but only harbored one. In a third family (this case), the variant is identified in homozygosity. This variant has also b een reported as a VUS in ClinVar (Variation ID# 179381). It has also been ident ified in 1/33580 Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). While the variant does not alter an amino aci d residue, computational tools suggest the creation of a cryptic splice site. Ho wever, this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Gly109Gly variant is uncertain but w e would lean towards a more likely pathogenic role. ACMG/AMP criteria applied: P M2, PM3, PP3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at